Company · CIK 0000832489 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
GeoVax Labs, Inc. · GOVX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 AForm 4 → | Jun 22, 4:22 pm EDT | John N Spencer Jr.Director | 6,000 | — | — | 6,000 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:21 pm EDT | Jayne MorganDirector | 6,000 | — | — | 6,000 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:21 pm EDT | Robert T McNallyDirector | 6,000 | — | — | 6,000 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:20 pm EDT | Nicole LemerondDirector | 6,000 | — | — | 6,000 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:20 pm EDT | Dean G KollintzasDirector | 6,000 | — | — | 6,000 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:19 pm EDT | Randal D ChaseDirector | 6,000 | — | — | 6,000 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:19 pm EDT | John W. SharkeyVP, Business Development | 17,600 | — | — | 17,600 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:18 pm EDT | Mark ReynoldsCFO | 17,600 | — | — | 17,600 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:18 pm EDT | Mark J NewmanChief Scientific Officer | 17,600 | — | — | 17,600 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:17 pm EDT | Kelly T. McKee Jr.Chief Medical Officer | 17,600 | — | — | 17,600 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 4:16 pm EDT | David A DoddPresident, CEO, Director | 29,300 | — | — | 29,300 | — |